(Q42862791)

8 November 2017

Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerization (English)

1 reference

8 November 2017

6

1 reference

8 November 2017

Anamaria Vidu

1

1 reference

8 November 2017

Laure Dufau

2

1 reference

8 November 2017

Ludovic Bannwarth

3

1 reference

8 November 2017

Jean-Louis Soulier

4

1 reference

8 November 2017

Sames Sicsic

5

1 reference

8 November 2017

Michèle Reboud-Ravaux

7

1 reference

8 November 2017

Sandrine Ongeri

8

1 reference

8 November 2017

1 November 2010

1 reference

8 November 2017

1 reference

8 November 2017

5

1 reference

8 November 2017

11

1 reference

8 November 2017

1899-1906

1 reference

Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases

8 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Folded monomer of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

The structural stability of the HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Toxicity of antiretroviral therapy and implications for drug development

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Antivirals and antiviral strategies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Dimerization inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

HIV-1 reproduction is inhibited by peptides derived frm the N- and C-termini of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Lipopeptides as dimerization inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Thyroxine-derivatives of lipopeptides: bifunctional dimerization inhibitors of human immunodeficiency virus-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Dimerization inhibitors of HIV-1 protease based on a bicyclic guanidinium subunit

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Restricting the flexibility of crosslinked, interfacial peptide inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000308

7 January 2021

Identifiers

DOI

10.1002/CMDC.201000308

1 reference

8 November 2017

1 reference